nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—Metoprolol—ABCB1—adrenal gland cancer	0.0918	0.272	CrCbGaD
Bevantolol—Verapamil—ABCB1—adrenal gland cancer	0.0702	0.208	CrCbGaD
Bevantolol—Propafenone—ABCB1—adrenal gland cancer	0.0677	0.201	CrCbGaD
Bevantolol—Carvedilol—ABCB1—adrenal gland cancer	0.0609	0.181	CrCbGaD
Bevantolol—Propranolol—ABCB1—adrenal gland cancer	0.0463	0.138	CrCbGaD
Bevantolol—ADRB2—Arf6 signaling events—TSHR—adrenal gland cancer	0.0362	0.0546	CbGpPWpGaD
Bevantolol—ADRB2—GPCRs, Other—GNRHR—adrenal gland cancer	0.0316	0.0476	CbGpPWpGaD
Bevantolol—ADRB2—Arf6 trafficking events—TSHR—adrenal gland cancer	0.0286	0.0431	CbGpPWpGaD
Bevantolol—ADRB1—Endothelin Pathways—GNAS—adrenal gland cancer	0.0226	0.034	CbGpPWpGaD
Bevantolol—ADRB1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0218	0.0328	CbGpPWpGaD
Bevantolol—ADRB2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0213	0.0321	CbGpPWpGaD
Bevantolol—ADRA1A—Endothelin Pathways—GNAS—adrenal gland cancer	0.0183	0.0275	CbGpPWpGaD
Bevantolol—ADRA1A—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0176	0.0265	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0147	0.0221	CbGpPWpGaD
Bevantolol—ADRB1—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0135	0.0203	CbGpPWpGaD
Bevantolol—ADRB2—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0132	0.0199	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0131	0.0198	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.012	0.0181	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0118	0.0177	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (12/13) signalling events—CDC42—adrenal gland cancer	0.00991	0.0149	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00972	0.0147	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00915	0.0138	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00895	0.0135	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00879	0.0133	CbGpPWpGaD
Bevantolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00834	0.0126	CbGpPWpGaD
Bevantolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00816	0.0123	CbGpPWpGaD
Bevantolol—ADRB2—Arf6 signaling events—EGFR—adrenal gland cancer	0.00802	0.0121	CbGpPWpGaD
Bevantolol—ADRB2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	0.008	0.0121	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00787	0.0119	CbGpPWpGaD
Bevantolol—ADRB1—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00783	0.0118	CbGpPWpGaD
Bevantolol—ADRB2—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00766	0.0115	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0074	0.0112	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0072	0.0109	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00704	0.0106	CbGpPWpGaD
Bevantolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00676	0.0102	CbGpPWpGaD
Bevantolol—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00675	0.0102	CbGpPWpGaD
Bevantolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00661	0.00997	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00642	0.00967	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00628	0.00946	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00582	0.00878	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00548	0.00827	CbGpPWpGaD
Bevantolol—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00547	0.00825	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00536	0.00809	CbGpPWpGaD
Bevantolol—ADRB1—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00527	0.00795	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00519	0.00783	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00517	0.0078	CbGpPWpGaD
Bevantolol—ADRB2—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00516	0.00777	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00506	0.00763	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00489	0.00737	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00478	0.00721	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0047	0.00708	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00459	0.00693	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00444	0.00669	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00418	0.00631	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00395	0.00596	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0038	0.00573	CbGpPWpGaD
Bevantolol—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	0.00324	0.00488	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0031	0.00467	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00303	0.00457	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00284	0.00429	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00281	0.00424	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00278	0.00419	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00277	0.00418	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00276	0.00416	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00275	0.00415	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00271	0.00409	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0027	0.00407	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00258	0.00389	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00252	0.0038	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00251	0.00379	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00251	0.00378	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00251	0.00378	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00246	0.00371	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00245	0.0037	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00242	0.00366	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00237	0.00358	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.0023	0.00347	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00228	0.00343	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00224	0.00338	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00223	0.00337	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00209	0.00315	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00203	0.00307	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.00203	0.00306	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00196	0.00296	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	0.00191	0.00289	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	0.00187	0.00282	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0018	0.00271	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00176	0.00265	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00168	0.00253	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00166	0.00251	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00164	0.00248	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00163	0.00245	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00161	0.00242	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00157	0.00237	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00155	0.00234	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.00155	0.00233	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00153	0.0023	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00152	0.00229	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	0.00149	0.00225	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	0.00149	0.00224	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	0.00148	0.00223	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00146	0.0022	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00146	0.0022	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	0.00145	0.00218	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00143	0.00215	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	0.00139	0.0021	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	0.00136	0.00205	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00136	0.00205	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.00134	0.00203	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0013	0.00196	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00123	0.00186	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.00123	0.00185	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.0012	0.00181	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.00118	0.00178	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.00113	0.0017	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00108	0.00163	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00106	0.0016	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	0.00106	0.0016	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	0.00104	0.00157	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	0.000982	0.00148	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	0.000961	0.00145	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.000902	0.00136	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	0.000882	0.00133	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000875	0.00132	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000869	0.00131	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000862	0.0013	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.00086	0.0013	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	0.00085	0.00128	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	0.000843	0.00127	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00084	0.00127	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000822	0.00124	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000795	0.0012	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.00073	0.0011	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	0.000723	0.00109	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	0.000708	0.00107	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000703	0.00106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000697	0.00105	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00068	0.00103	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	0.000629	0.000949	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	0.000616	0.000928	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000585	0.000883	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	0.00058	0.000875	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	0.000573	0.000864	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	0.000567	0.000856	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	0.00056	0.000845	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000555	0.000837	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000543	0.000819	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000509	0.000768	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000469	0.000708	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000463	0.000699	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000449	0.000677	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000414	0.000624	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000405	0.000611	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000335	0.000505	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	0.000328	0.000495	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	0.000321	0.000484	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	0.000275	0.000415	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	0.000269	0.000406	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000265	0.0004	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	0.000223	0.000336	CbGpPWpGaD
